Valuation: DarioHealth Corp.

Market Cap 70.56M 61.53M 58.09M 52.75M 98.84M 6.77B 99.25M 696M 269M 3.44B 265M 259M 11.08B P/E 2026 *
-1.89x
P/E 2027 * -3.2x
Enterprise Value 70.56M 61.53M 58.09M 52.75M 98.84M 6.77B 99.25M 696M 269M 3.44B 265M 259M 11.08B EV / Sales 2026 *
3.22x
EV / Sales 2027 * 2.32x
Free-Float
84.12%
Yield 2026 *
-
Yield 2027 * -
1 day+3.00%
1 week+3.90%
Current month-2.31%
1 month+0.42%
3 months+3.90%
6 months-9.89%
Current year-36.73%
1 week 6.65
Extreme 6.65
7.2
1 month 6.45
Extreme 6.45
7.72
Current year 5.84
Extreme 5.8445
13.64
1 year 5.84
Extreme 5.8445
17.74
3 years 5.84
Extreme 5.8445
69.8
5 years 5.84
Extreme 5.8445
387.8
10 years 5.84
Extreme 5.8445
1,880
Manager TitleAgeSince
Corporate Officer/Principal - 10/08/2011
Chief Executive Officer 52 08/08/2013
Director of Finance/CFO 38 31/12/2020
Director TitleAgeSince
Chairman 52 22/11/2014
Director/Board Member 68 11/11/2013
Director/Board Member 57 22/11/2014
Date Insider Type Main position Quantity % Market Cap. Importance
23/07/26 Buy

Director

14,430 0.1973%
10/04/26 Other

Director

4,500 0.0616%
11/09/25 Free

Director

20,000 0.0440%
Change 5-day change 1-year change 3-year change Capi.($)
+3.00%+3.90%+9.09%-88.16% 70.56M
+0.37%+0.65%-24.57%+2.32% 178B
-0.69%+1.29%-3.10%+13.07% 118B
-0.20%-3.98%+6.47%+68.94% 58.92B
-0.24%+1.74%-3.26%-32.27% 49.29B
-0.22%-0.37%+10.27%+42.75% 48.17B
+1.61%+7.61%+32.47%-3.54% 33.72B
-1.49%-2.74% - - 27.76B
-1.17%+4.64%+42.17%-5.73% 25.5B
+1.02%+5.99%+6.51%-17.36% 22.1B
Average +0.20%+1.87%+8.45%-2.22% 56.09B
Weighted average by Cap. -0.08%+0.95%-3.19%+10.93%

Financials

2026 *2027 *
Net sales 21.88M 19.08M 18.02M 16.36M 30.65M 2.1B 30.78M 216M 83.29M 1.07B 82.2M 80.38M 3.43B 30.37M 26.48M 25M 22.7M 42.54M 2.91B 42.72M 300M 116M 1.48B 114M 112M 4.77B
Net income -32.62M -28.45M -26.86M -24.39M -45.7M -3.13B -45.89M -322M -124M -1.59B -123M -120M -5.12B -21.4M -18.66M -17.62M -16M -29.97M -2.05B -30.1M -211M -81.43M -1.04B -80.37M -78.59M -3.36B
Net Debt - -
Logo DarioHealth Corp.
DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Employees
163
Date Price Change Volume
18/09/26 US$7.200 +3.00% 28,213
17/09/26 US$6.990 +3.10% 20,062
16/09/26 US$6.780 +0.44% 9,000
15/09/26 US$6.750 -4.80% 6,043
14/09/26 US$7.090 +2.31% 31,038
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
7.200USD
Average target price
13.60USD
Spread / Average Target
+88.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DRIO Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!